Israel Englander’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.1M | Buy |
+73,809
| New | +$1.61M | ﹤0.01% | 3778 |
|
|
2026
Q1 | – | Sell |
-99,735
| Closed | -$1.88M | – | 5772 |
|
|
2025
Q4 | $1.88M | Sell |
99,735
-313,954
| -76% | -$5.26M | ﹤0.01% | 4001 |
|
|
2025
Q3 | $6.02M | Buy |
413,689
+345,197
| +504% | +$4.92M | ﹤0.01% | 2942 |
|
|
2025
Q2 | $1.34M | Sell |
68,492
-34,117
| -33% | -$606K | ﹤0.01% | 4204 |
|
|
2025
Q1 | $1.82M | Sell |
102,609
-518,698
| -83% | -$11.2M | ﹤0.01% | 3868 |
|
|
2024
Q4 | $13.3M | Buy |
621,307
+170,568
| +38% | +$4.15M | 0.01% | 1899 |
|
|
2024
Q3 | $14.1M | Sell |
450,739
-1,690,170
| -79% | -$42.1M | 0.01% | 1872 |
|
|
2024
Q2 | $33.2M | Buy |
2,140,909
+1,960,308
| +1,085% | +$23.7M | 0.02% | 1080 |
|
|
2024
Q1 | $1.91M | Sell |
180,601
-77,461
| -30% | -$775K | ﹤0.01% | 3782 |
|
|
2023
Q4 | $3.1M | Buy |
258,062
+184,239
| +250% | +$1.51M | ﹤0.01% | 3216 |
|
|
2023
Q3 | $517K | Sell |
73,823
-299,655
| -80% | -$2.77M | ﹤0.01% | 4638 |
|
|
2023
Q2 | $3.17M | Sell |
373,478
-1,326,322
| -78% | -$11.1M | ﹤0.01% | 3092 |
|
|
2023
Q1 | $15.5M | Buy |
1,699,800
+988,259
| +139% | +$12.6M | 0.01% | 1556 |
|
|
2022
Q4 | $8.12M | Buy |
711,541
+200,672
| +39% | +$2.97M | ﹤0.01% | 2355 |
|
|
2022
Q3 | $8.7M | Buy |
510,869
+10,000
| +2% | +$215K | 0.01% | 2315 |
|
|
2022
Q2 | $10.8M | Sell |
500,869
-109,857
| -18% | -$3.05M | 0.01% | 1947 |
|
|
2022
Q1 | $22.6M | Sell |
610,726
-175,445
| -22% | -$6.84M | 0.01% | 1267 |
|
|
2021
Q4 | $35.8M | Buy |
786,171
+431,521
| +122% | +$22.5M | 0.02% | 954 |
|
|
2021
Q3 | $22.5M | Sell |
354,650
-189,512
| -35% | -$14.4M | 0.01% | 1219 |
|
|
2021
Q2 | $49.8M | Buy |
544,162
+490,554
| +915% | +$39M | 0.03% | 606 |
|
|
2021
Q1 | $3.65M | Sell |
53,608
-35,335
| -40% | -$2.74M | ﹤0.01% | 2933 |
|
|
2020
Q4 | $6.44M | Sell |
88,943
-394,454
| -82% | -$22.9M | ﹤0.01% | 2196 |
|
|
2020
Q3 | $18.3K | Buy |
483,397
+4,471
| +0.9% | +$151K | 0.02% | 846 |
|
|
2020
Q2 | $17M | Buy |
478,926
+297,116
| +163% | +$8.46M | 0.02% | 837 |
|
|
2020
Q1 | $3.97M | Sell |
181,810
-113,934
| -39% | -$2.55M | 0.01% | 1503 |
|
|
2019
Q4 | $6.38M | Buy |
295,744
+157,491
| +114% | +$3.61M | 0.01% | 1725 |
|
|
2019
Q3 | $3.13M | Sell |
138,253
-63,175
| -31% | -$1.75M | ﹤0.01% | 2145 |
|
|
2019
Q2 | $7.25M | Buy |
201,428
+94,026
| +88% | +$3.01M | 0.01% | 1496 |
|
|
2019
Q1 | $3.38M | Sell |
107,402
-55,621
| -34% | -$1.62M | 0.01% | 2032 |
|
|
2018
Q4 | $4.1M | Buy |
163,023
+58,280
| +56% | +$1.5M | 0.01% | 1721 |
|
|
2018
Q3 | $3.02M | Sell |
104,743
-137,870
| -57% | -$2.58M | ﹤0.01% | 2136 |
|
|
2018
Q2 | $2.97M | Buy |
242,613
+82,461
| +51% | +$946K | ﹤0.01% | 2143 |
|
|
2018
Q1 | $1.28M | Buy |
160,152
+114,314
| +249% | +$705K | ﹤0.01% | 2569 |
|
|
2017
Q4 | $336K | Buy |
+45,838
| New | +$286K | ﹤0.01% | 3289 |
|
Other funds holding CDNA
DM
AIM
GS
Israel Englander's CDNA Position: Q2 2026 in Review
Israel Englander opened a new position in CareDx (CDNA) in Q2 2026: 73,809 shares worth $2.1M. The stake represents ﹤0.01% of the portfolio and ranks #3778 among its holdings. This is a return to the name: Israel Englander previously reported a position in CDNA as recently as Q4 2025.
Israel Englander first reported a position in CDNA in Q4 2017 and has held it in 34 quarters since. The position peaked at $49.8M in Q2 2021. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Israel Englander held 73,809 shares of CareDx worth $2.1M as of Q2 2026.
- CareDx was a new Israel Englander position in Q2 2026.
- CareDx made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3778 holding.
- Israel Englander first reported a position in CareDx in Q4 2017 and has held it in 34 quarters since.
- Israel Englander's CareDx position peaked at $49.8M in Q2 2021.
- 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.